These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 22767438

  • 1. Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.
    Zeng ZL, Li FJ, Gao F, Sun DS, Yao L.
    J Surg Oncol; 2013 Feb; 107(2):105-10. PubMed ID: 22767438
    [Abstract] [Full Text] [Related]

  • 2. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
    Fang F, Luo LB, Tao YM, Wu F, Yang LY.
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
    [Abstract] [Full Text] [Related]

  • 3. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [Abstract] [Full Text] [Related]

  • 4. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS, Wang F, Chen TC, Yeh CN, Yu MC, Jan YY, Chen MF.
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [Abstract] [Full Text] [Related]

  • 5. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K.
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [Abstract] [Full Text] [Related]

  • 6. Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells.
    Hu X, Feng Y, Sun L, Qu L, Sun C.
    Dig Dis Sci; 2017 Mar; 62(3):715-722. PubMed ID: 28050784
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.
    Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881
    [Abstract] [Full Text] [Related]

  • 8. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
    Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang Y, Zhao J, McCrae MA, Zhuang H.
    Cancer; 2012 May 01; 118(9):2431-42. PubMed ID: 21989846
    [Abstract] [Full Text] [Related]

  • 9. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
    Petrelli A, Perra A, Schernhuber K, Cargnelutti M, Salvi A, Migliore C, Ghiso E, Benetti A, Barlati S, Ledda-Columbano GM, Portolani N, De Petro G, Columbano A, Giordano S.
    Oncogene; 2012 Oct 18; 31(42):4517-26. PubMed ID: 22249248
    [Abstract] [Full Text] [Related]

  • 10. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.
    J Gastroenterol Hepatol; 2012 Jan 18; 27(1):173-80. PubMed ID: 21777276
    [Abstract] [Full Text] [Related]

  • 11. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
    Zhi Q, Zhu J, Guo X, He S, Xue X, Zhou J, Hu B, Li H, Chen S, Zhao H, Kuang Y.
    Biomed Pharmacother; 2013 Jun 18; 67(5):393-8. PubMed ID: 23648054
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
    Xu D, He XX, Chang Y, Sun SZ, Xu CR, Lin JS.
    Hepatogastroenterology; 2012 Jun 18; 59(120):2367-73. PubMed ID: 22773266
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression and prognostic value of ING3 in human primary hepatocellular carcinoma.
    Yang HY, Liu HL, Tian LT, Song RP, Song X, Yin DL, Liang YJ, Qu LD, Jiang HC, Liu JR, Liu LX.
    Exp Biol Med (Maywood); 2012 Apr 18; 237(4):352-61. PubMed ID: 22550337
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
    Yunqiao L, Vanke H, Jun X, Tangmeng G.
    Hepatogastroenterology; 2014 Apr 18; 61(133):1302-7. PubMed ID: 25436301
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.